介质干细胞衍生异体对癌细胞的双重影响:揭开复杂的相互作用
Babak Jahangiri1,2,3, Mohammad Khalaj-Kondori4, Elahe Asadollahi2,3
1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
Journal of cell communication and signaling
|November 16, 2023
概括
介质干细胞衍生的外体细胞 (MSC-Exos) 可以促进或抑制癌症的生长,影响瘤的进展,转移和免疫反应. 它们在癌症治疗中的治疗潜力,特别是通过miRNA调制,正在研究中.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物医学科学 生物医学科学
背景情况:
- 介酶干细胞 (MSCs) 是具有瘤定位能力的多能干细胞.
- MSCs释放出细胞外囊泡,称为外体 (MSC-Exos),调解细胞与细胞之间的通信.
- MSC-Exos可以影响受体细胞的表型和功能,提供一种无细胞的治疗替代方案.
研究的目的:
- 审查MSC-Exos对癌症的多方面的影响.
- 阐明MSC-Exos在瘤发生,血管生成和转移中的双重作用.
- 探索MSC-Exos在癌症治疗中的潜力,包括miRNA恢复.
主要方法:
- 对研究MSC-Exos及其与癌细胞相互作用的研究文献综述.
- 对外体内容转移及其对瘤微环境的影响的分析.
- 检查MSC-Exos对癌症特征的影响,如生长,转移和免疫调节.
主要成果:
- MSC-Exos对癌细胞表现出相反的作用,可能促进或抑制瘤的进展.
- MSC-Exos调节关键的癌症过程,包括上皮层-介质细胞过渡 (EMT),血管新生和转移.
- MSC-Exos的影响取决于瘤微环境线索和受体癌细胞特征.
- MSC-Exos影响化学疗法和放射治疗的耐药性,并调节免疫系统.
结论:
- MSC-Exos是瘤利基的显著调节剂,对癌症具有复杂和取决于背景的影响.
- 理解MSC-Exos的双重作用对于开发有效的癌症疗法至关重要.
- 作为癌症的无细胞治疗策略,MSC-Exos具有前景,特别是通过miRNA输送.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


